CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $89,088
- in 5 filings, $89K under 10b5-1 plans
Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-15 | Hirsch Andrew Director | Grant or award · Stock Option (right to buy) | +11,538 | 11,538 | ||
| 2018-06-13 | Albright Charles Chief Scientific Officer | Option exercise | +10,000 | $16.51 | $165K | 10,000 |
| 2018-06-13 | Albright Charles Chief Scientific Officer | Sale | −10,000 | $35.98 | $360K | 0 |
| 2018-06-13 | Albright Charles Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −10,000 | 205,000 | ||
| 2018-06-04 | Hack Andrew A. F. Chief Financial Officer | Option exercise | +3,000 | $24.60 | $74K | 3,000 |
| 2018-06-04 | Hack Andrew A. F. Chief Financial Officer | Sale | −3,000 | $37.10 | $111K | 0 |
| 2018-06-04 | Hack Andrew A. F. Chief Financial Officer | Option exercise · Stock Option (right to buy) | −3,000 | 67,500 | ||
| 2018-06-01 | Hack Andrew A. F. Chief Financial Officer | Option exercise | +5,000 | $6.48 | $32K | 5,000 |
| 2018-06-01 | Hack Andrew A. F. Chief Financial Officer | Sale | −5,000 | $39.05 | $195K | 0 |
| 2018-06-01 | Hack Andrew A. F. Chief Financial Officer | Option exercise | +2,000 | $6.48 | $13K | 2,000 |
| 2018-06-01 | Hack Andrew A. F. Chief Financial Officer | Sale | −2,000 | $39.86 | $80K | 0 |
| 2018-06-01 | Hack Andrew A. F. Chief Financial Officer | Option exercise · Stock Option (right to buy) | −7,000 | 41,513 | ||
| 2018-06-01 | Bosley Katrine President and CEO | Sale | −6,214 | $37.18 | $231K | 1,295,751 |
| 2018-06-01 | Bosley Katrine President and CEO | Sale | −1,019 | $37.81 | $39K | 1,294,732 |
| 2018-06-01 | Bosley Katrine President and CEO | Sale | −800 | $39.15 | $31K | 1,293,932 |
| 2018-06-01 | Bosley Katrine President and CEO | Sale | −300 | $39.96 | $12K | 1,293,632 |
| 2018-05-23 | Albright Charles Chief Scientific Officer | Option exercise | +10,000 | $16.51 | $165K | 10,000 |
| 2018-05-23 | Albright Charles Chief Scientific Officer | Sale | −10,000 | $35.00 | $350K | 0 |
| 2018-05-23 | Albright Charles Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −10,000 | 215,000 | ||
| 2018-05-18 | MULLEN JAMES C Director | Purchase | +10,000 | $38.03 | $380K | 10,000 |
Page 19 of 30 · 588 trades